The short version
- Cervical cancer is the only gynecologic cancer with an established screening test for women at average risk.
- There is no screening test for uterine, ovarian, vulvar, or vaginal cancer in women at average risk.
- For uterine cancer, reporting bleeding after menopause is the screening. It catches about ninety percent of cases. [1]
- The HPV vaccine prevents the infections that cause most cervical, vulvar, and vaginal cancers. [2]
- A yearly visit is still worth keeping even when no Pap test is due that year.
The plain truth
Patients are often surprised by this, so it is worth saying plainly. A Pap test screens the cervix. It does not screen the ovaries, the uterus, the vulva, or the vagina. A normal Pap result is good news about one organ.
| Is there a screening test for average risk? | What finds it early | |
|---|---|---|
| Cervical | Yes | Pap and HPV testing on a schedule. See the screening page. |
| Uterine (endometrial) | No | Reporting any bleeding after menopause. About 91 percent of endometrial cancers present with it. [1] |
| Ovarian | No | Noticing bloating, pelvic pain, early fullness, or urinary changes that are new, daily, and worsening. [3] |
| Vulvar | No | A biopsy of any lump, sore, or itch that does not resolve. [4] |
| Vaginal | No | Evaluation of unexplained bleeding or discharge, often found during a Pap or pelvic exam. |
Cervical cancer
This is the one where prevention genuinely works, and it works two ways. Vaccination stops the infection that causes it. Screening finds the changes that come before cancer, while they are still easy to treat. Together they can prevent most cases. Read the screening schedule and the HPV vaccine page.
Uterine cancer
There is no test to hand you here. What there is, is a rule: any vaginal bleeding after menopause gets evaluated. In a review of 129 studies covering more than 40,000 women, about 91 percent of women with endometrial cancer had postmenopausal bleeding, and about 9 percent of women with postmenopausal bleeding turned out to have endometrial cancer. [1] Both numbers matter. The first is why reporting bleeding works as well as any screening test we have. The second is why most women who report it get good news.
If uterine or colon cancer runs in your family, ask about Lynch syndrome. It changes what we watch for and when. [5]
Ovarian cancer
CA-125 blood tests and pelvic ultrasounds are not recommended as screening for women at average risk. They are useful once we are investigating a symptom or following a known cancer. [3]
Inherited risk is different. If you carry a BRCA1 or BRCA2 gene change, or a strong family history points that way, there are real risk-reducing options, and the time to talk about them is long before any symptom. Ask for genetic counseling.
Vulvar and vaginal cancer
There is no screening test. What finds these early is looking, and biopsying anything that has not resolved. If you have been treated more than once for the same vulvar itch or sore without it going away, ask directly for a biopsy. [4]
What a well-woman visit covers
Even in a year when no Pap test is due, the visit is worth keeping. It is where bleeding gets mentioned, where a skin change gets looked at, where family history gets updated, and where vaccines get caught up. The well-woman visit page walks through what to expect and what to bring.
Prevention and screening checklist
A one-page printable summary of what is screened, what is not, and what to report. This printable guide is in development. In the meantime, everything it will contain is on this page, and the office can walk you through it. See the handouts we do have.
Sources
- Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA Intern Med. 2018;178(9):1210-1222. Retrieved from PubMed (PMID 30083701). https://doi.org/10.1001/jamainternmed.2018.2820
- Centers for Disease Control and Prevention. HPV Vaccination. Last reviewed August 20, 2024, accessed August 21, 2026. https://www.cdc.gov/hpv/vaccines/index.html
- National Cancer Institute. Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ) Patient Version. Updated November 22, 2024. https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq
- National Cancer Institute. Vulvar Cancer Treatment (PDQ) Patient Version. Updated September 18, 2024. https://www.cancer.gov/types/vulvar/patient/vulvar-treatment-pdq
- Society of Gynecologic Oncology. Uterine Cancer and Lynch Syndrome. Accessed August 21, 2026. https://www.sgo.org/patient-resources/uterine-cancer/uterine-cancer-lynch-syndrome/
- Society of Gynecologic Oncology. Ovarian Cancer Symptoms. Accessed August 21, 2026. https://www.sgo.org/patient-resources/ovarian-cancer/ovarian-cancer-symptoms/
Reviewed by DeEtte R. Vasques, DO, MBA · September 2026